Ghrelin as a potential blood pressure reducing factor in obese women during weight loss treatment

Endokrynologia Polska

Volumn 59, Issue 3, 2008, Pages 207-211

  Mizia Stec, Katarzyna ^a   Zahorska Markiewicz, Barbara ^a   Olszanecka Glinianowicz, Magdalena ^a   Janowska, Joanna ^a   Mucha, Zbigniew ^a   Holecki, Michał ^a   Gasior, Zbigniew ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Arterial blood pressure; Ghrelin; Obesity; Weight loss

Indexed keywords

GHRELIN;

ADULT; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BODY COMPOSITION; BODY FAT; BODY MASS; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; FEMALE; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; KINESIOTHERAPY; LOW CALORY DIET; OBESITY; SYSTOLIC BLOOD PRESSURE; WEIGHT REDUCTION;

ADULT; BLOOD PRESSURE; DIET, REDUCING; FEMALE; GHRELIN; HUMANS; OBESITY; WEIGHT LOSS;

EID: 52249099899     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Ukkola O, Poykko S. Ghrelin, growth and obesity. Ann Med 2001; 34: 102-108.
2. Shiija T, Nakazato M, Mizuta M et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 2002; 87: 240-244.
3. Marzullo P, Verti B, Savia G et al. The relationship between active ghrelin levels and human obesity involves alterations in resting energy expenditure. J Clin Endocrinol Metab 2004; 89: 936-939.
4. Lin Y, Matsumura K, Fukuhara M et al. Ghrelin acts at the nucleus of the solitary tract to decrease arterial pressure in rats. Hypertension 2004; 43: 977-982.
5. Snitker S, Macdonald I, Ravussin E et al. The sympathetic nervous system and obesity: role in aetiology and treatment. Obes Rev 2000; 1: 5-15.
6. Nagaya N, Kojima M, Uematsu M et al. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol 2001; 280: 1483-1487.
7. Krawczyńka-Drózdz A, Olszanecki R, Jawien J et al. Ghrelin inhibits vascular superoxide production in spontaneously hypertensive rats. Am J Hypertens 2006; 19: 764-767.
8. Mager U, Kolehmainen M, Lindstrom J et al. Association between ghrelin gene variations and blood pressure in subjects with impaired glucose tolerance. Am J Hypertens 2006; 19: 920-926.
9. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
10. Zahorska-Markiewicz B, Mizia-Stec K, Olszanecka-Glinianowicz M et al. Effect of weight reduction on serum ghrelin and TNFa concentrations in obese women. Eur J Int Med 2004; 15: 172-175.
11. Matsumura K, Tsuchihashi T, Fujii K et al. Neural regulation of blood pressure by leptin and the related peptides. Regul Pept 2003; 114: 79-86.
12. Matsumura K, Tsuchihashi T, Fujii K et al. Central ghrelin modulates sympathetic activity in conscious rabbits. Hypertension 2002; 40: 694-699.
13. Makino Y, Hosoda H, Shibata K. Alteration of plasma ghrelin levels associated with the blood pressure in pregnancy. Hypertension 2002; 39: 781-784.
14. Poykko SM, Kelloloski E, Horkko S et al. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 2003; 52: 2546-2553.
15. Greenman Y, Golani N, Gilad S et al. Ghrelin secretion is modulated in a nutrient- and gender-specific manner. Clin Endocrinol 2004; 60:382-388.
16. Nagaya N, Uematsu M, Kojima M et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 2001; 104: 1430-1435.
17. Nagaya N, Uematsu M, Kojima M et al. Elevated circulating level of ghrelin in cachexia associated with chronic heart failure. Circulation 2001; 104: 2034-2038.